Neuropeptide S Ameliorates Cognitive Impairment of APP/PS1 Transgenic Mice by Promoting Synaptic Plasticity and Reducing Aβ Deposition

Alzheimer’s disease (AD) is a devastating disease in the elderly with no known effective treatment. It is characterized by progressive deterioration of memory and cognition. Many new potential targets are being investigated to develop effective therapeutic strategies for AD. Neuropeptide S (NPS) is...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Peng Zhao, Xiaohang Qian, Yunjuan Nie, Na Sun, Zhongxuan Wang, Jiajun Wu, Chen Wei, Ruikun Ma, Zhe Wang, Gaoshang Chai, Yuqing Li
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2019-06-01
Serija:	Frontiers in Behavioral Neuroscience
Teme:	Alzheimer’s disease Neuropeptide S Aβ cognitive deficits synaptic plasticity
Online dostop:	https://www.frontiersin.org/article/10.3389/fnbeh.2019.00138/full
Oznake:	Označite Brez oznak, prvi označite!